Canaan Partners
Venture capital · Menlo Park, California, United States
Portfolio collected from the firm’s website, last checked Jun 28, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio5 active
1Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Joby Aviation
28Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Cohere | Software | Active | Feb 2, 2023 | $1.1M |
| Draig Therapeutics | Biotech | Active | — | — |
| F2G | Biotech | Active | — | — |
| Graywolf Therapeutics | Biotech | Active | — | — |
| Vima Therapeutics | Biotech | Active | — | — |
| Joby Aviation | Space | Public | Aug 19, 2026 | $560.0M |
Peer ranks
Portfolio size#67
Portfolio exits#160
Raises, 12 months#22
Co-investors#64
Co-investors
- Access BiotechnologyVenture capital2 shared
- Sanofi VenturesVenture capital2 shared
- SR OneVenture capital2 shared
- SV Health InvestorsVenture capital2 shared
- AeroVironmentVenture capital1 shared
- Airbus VenturesVenture capital1 shared
- AmazonVenture capital1 shared
- American AirlinesVenture capital1 shared
- Andreessen HorowitzVenture capital1 shared
- Atlas VentureVenture capital1 shared
Sectors
- Biotech4
- Software1
- Space1
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.